European Patent Office

T 0254/93 (Prevention of skin atrophy) vom 14.05.1997

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:1997:T025493.19970514
Datum der Entscheidung
14. Mai 1997
Aktenzeichen
T 0254/93
Antrag auf Überprüfung von
-
Anmeldenummer
87309681.2
IPC-Klasse
A61K 31/57
Verfahrenssprache
Englisch
Verteilung
Im Amtsblatt des EPA veröffentlicht (A)
Amtsblattfassungen
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Prévention de l'atrophie de la peau induite par les gluco- corticoides
Name des Antragstellers
ORTHO PHARMACEUTICAL
Name des Einsprechenden
-
Kammer
3.3.02
Leitsatz

When a second medical indication is claimed in relation with a constiuent in the preparation of a known composition and the final effect is apparent in using the known composition for the known purpose, a technical problem can be seen neither in the obtention of the final effect nor in the preparation of the composition. The only remaining question could be the explanation of the phenomenon underlying the treatment according to the known process (see reasons pt. 4.4).

The mere explanation of an effect obtained when using a compound in a known composition, even if the effect was not known to be due to this compound in the known composition, cannot confer novelty to a known process if the skilled person was already aware of the occurrence of the desired effect (see reasons pt. 4.8).

Schlagwörter
Novelty (no)
Novel use as a technical feature respectively technical effect within the meaning of G 2/88 denied - effects tied up and both apparent from prior use
Orientierungssatz
-

ORDER

For these reasons it is decided that:

1. The appeal is dismissed.

2. The requests for reimbursement of the appeal fee and for referral to the Enlarged Board of Appeal are refused.